Cost-effectiveness analysis of pirfenidone versus nintedanib on the treatment of idiopathic pulmonary fibrosis

Authors
Category Systematic review
JournalValue in Health
Year 2017
This article has no abstract
Epistemonikos ID: 3b4b0e337a22af38ff1b7d300623588c28804284
First added on: Feb 08, 2025